For example, interesting studies by Crittenden and colleagues have shown that knockout of Mertk in macrophages improves radiotherapy outcomes [148], while more recent studies using anti-Mertk neutralizing antibodies have shown that blocking Mertk-dependent efferocytosis induces a secondary necrosis of tumor cells that release cGAMP [149]. The gene discussed is MERTK; the disease is neoplasm.